Compounds > rc 3095
Page last updated: 2024-09-03

rc 3095 and Cancer of Mouth

rc 3095 has been researched along with Cancer of Mouth in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crean, DH; Liebow, C; Mang, TS; Schally, AV1
Crean, DH; Liebow, C; Mang, TS; Penetrante, RB1
Kozacko, MF; Liebow, C; Mang, TS; Priore, RL; Schally, AV1

Other Studies

3 other study(ies) available for rc 3095 and Cancer of Mouth

ArticleYear
Peptide analogues alter the progression of premalignant lesions, as measured by Photofrin fluorescence.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Mar-01, Volume: 90, Issue:5

    Topics: Animals; Bombesin; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cocarcinogenesis; Cricetinae; Fluorescent Dyes; Hematoporphyrin Derivative; Microscopy, Fluorescence; Mouth Neoplasms; Peptide Fragments; Peptides; Somatostatin

1993
Evaluation of porfimer sodium fluorescence for measuring tissue transformation.
    Cancer, 1993, Nov-15, Volume: 72, Issue:10

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Bombesin; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cheek; Cricetinae; Dihematoporphyrin Ether; Disease Models, Animal; Fluorescence; Mesocricetus; Mouth Neoplasms; Peptide Fragments; Photometry; Protein-Tyrosine Kinases; Somatostatin

1993
Bombesin antagonist prevents CO2 laser-induced promotion of oral cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 1996, Apr-02, Volume: 93, Issue:7

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Bombesin; Cricetinae; Dihematoporphyrin Ether; Lasers; Mouth Neoplasms; Neoplasms, Radiation-Induced; Peptide Fragments; Precancerous Conditions; Time Factors

1996